Rejuvenation Technologies
Rejuvenation Technologies develops targeted mRNA therapies intended to extend telomeres and restore cellular regenerative capacity in age-related disease.
UndisclosedInvestment
Role not disclosedJV
Jetstream Venture Fund
Activity from announced rounds
Activity in this selectionOct 18, 2026 · Sep 19, 2026
Jetstream Venture Fund is the specified fund named in Wonderlab Bio and Rejuvenation financing histories.
Recorded funding activity
Wonderlab develops donor-derived cell therapies intended for broad patient access. Rejuvenation develops targeted mRNA approaches intended to restore regenerative capacity. Their relationships belong to this named vehicle, with draft status retained where applicable.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share